Medscape

FDA Grants Emergency Authorization for First Rapid Antibody Test for COVID-19

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The U.S. Food and Drug Administration has granted Cellex an emergency use authorization to market a ...
Nasdaq

Biohaven Reports Positive Phase 1 Degrader Data, Achieving Deep Targeted IgG Reductions in the Lowest Subcutaneous Dose Tested; Announces NDA Submission for Troriluzole in SCA ...

BHV-1300 achieved deep lowering of targeted IgG, with reductions > 60% in the lowest subcutaneous dose tested in the MAD. Subcutaneous BHV-1300 achieved rapid and progressive lowering of IgG within ...
Medscape

Warfarin and a Positive IgG Anticardiolipin Antibody Test Result

I recently saw a patient with 2 transient ischemic attack-like episodes of regional limb weakness and parasthesias lasting for short periods without sequelae. Testing revealed a moderately elevated ...
Morningstar

Biohaven Reports Positive Degrader Data Achieving > 80% Sustained Reductions in Total IgG with Potential First-in-Class BHV-1300

Optimized subcutaneous administration of BHV-1300 achieved rapid, deep and sustained lowering of IgG, differentiating Biohaven's new small molecule class of degraders from the monoclonal antibody FcRn ...